Mylan CEO: Reformulating EpiPen to Have Longer Shelf Life

The transcript discusses the company's R&D spending, focusing on access and awareness programs for EpiPen. It highlights efforts to develop new devices based on patient feedback and improve the product's shelf life. The goal is to extend the shelf life to 24 months, with plans to submit findings to the FDA soon. Continued work on stability may further extend the shelf life beyond 24 months.

What are the main areas where the majority of spending has been focused according to the text?

What is the projected shelf life for the EpiPen as mentioned in the text?

What is the minimum shelf life that the researchers are hopeful to achieve for the EpiPen?

How long have the researchers been working on the EpiPen project as mentioned in the text?

What is the significance of submitting the EpiPen to the FDA according to the discussion?